248 related articles for article (PubMed ID: 33089423)
21. Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.
Luo P; Chu SF; Zhang Z; Xia CY; Chen NH
Brain Res Bull; 2019 Mar; 146():12-21. PubMed ID: 30496784
[TBL] [Abstract][Full Text] [Related]
22. CX3CL1/CX3CR1 axis attenuates early brain injury via promoting the delivery of exosomal microRNA-124 from neuron to microglia after subarachnoid hemorrhage.
Chen X; Jiang M; Li H; Wang Y; Shen H; Li X; Zhang Y; Wu J; Yu Z; Chen G
J Neuroinflammation; 2020 Jul; 17(1):209. PubMed ID: 32664984
[TBL] [Abstract][Full Text] [Related]
23. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.
Szukiewicz D
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731899
[TBL] [Abstract][Full Text] [Related]
24. Defective fractalkine-CX3CR1 signaling aggravates neuroinflammation and affects recovery from cuprizone-induced demyelination.
Mendiola AS; Church KA; Cardona SM; Vanegas D; Garcia SA; Macklin W; Lira SA; Ransohoff RM; Kokovay E; Lin CA; Cardona AE
J Neurochem; 2022 Sep; 162(5):430-443. PubMed ID: 35560167
[TBL] [Abstract][Full Text] [Related]
25. Role of Fractalkine-CX3CR1 Axis in Acute Rejection of Mouse Heart Allografts Subjected to Ischemia Reperfusion Injury.
Kanzawa T; Tokita D; Saiga K; Yamakawa T; Ishigooka H; Fukuda H; Katsumata H; Miyairi S; Ishii R; Hirai T; Imai T; Okumi M; Tanabe K
Transpl Int; 2022; 35():10157. PubMed ID: 35185378
[TBL] [Abstract][Full Text] [Related]
26. Microglial CX3CR1 promotes adult neurogenesis by inhibiting Sirt 1/p65 signaling independent of CX3CL1.
Sellner S; Paricio-Montesinos R; Spieß A; Masuch A; Erny D; Harsan LA; Elverfeldt DV; Schwabenland M; Biber K; Staszewski O; Lira S; Jung S; Prinz M; Blank T
Acta Neuropathol Commun; 2016 Sep; 4(1):102. PubMed ID: 27639555
[TBL] [Abstract][Full Text] [Related]
27. CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease.
Bivona G; Iemmolo M; Ghersi G
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175935
[TBL] [Abstract][Full Text] [Related]
28. The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders.
Pawelec P; Ziemka-Nalecz M; Sypecka J; Zalewska T
Cells; 2020 Oct; 9(10):. PubMed ID: 33065974
[TBL] [Abstract][Full Text] [Related]
29. Role of MSK1 in the Induction of NF-κB by the Chemokine CX3CL1 in Microglial Cells.
Galán-Ganga M; García-Yagüe ÁJ; Lastres-Becker I
Cell Mol Neurobiol; 2019 Apr; 39(3):331-340. PubMed ID: 30830503
[TBL] [Abstract][Full Text] [Related]
30. Involvement of CX3CL1/CX3CR1 in depression and cognitive impairment induced by chronic unpredictable stress and relevant underlying mechanism.
Liu Y; Zhang T; Meng D; Sun L; Yang G; He Y; Zhang C
Behav Brain Res; 2020 Mar; 381():112371. PubMed ID: 31765724
[TBL] [Abstract][Full Text] [Related]
31. A novel role of FKN/CX3CR1 in promoting osteogenic transformation of VSMCs and atherosclerotic calcification.
Yang T; Guo L; Chen L; Li J; Li Q; Pi Y; Zhu J; Zhang L
Cell Calcium; 2020 Nov; 91():102265. PubMed ID: 32814243
[TBL] [Abstract][Full Text] [Related]
32. Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke.
Walter HL; van der Maten G; Antunes AR; Wieloch T; Ruscher K
J Neuroinflammation; 2015 Feb; 12():24. PubMed ID: 25881123
[TBL] [Abstract][Full Text] [Related]
33. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway.
Huang L; Ma B; Ma J; Wang F
Biochem Biophys Res Commun; 2017 Dec; 493(4):1510-1517. PubMed ID: 28986258
[TBL] [Abstract][Full Text] [Related]
34. Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice.
Song KH; Park J; Park JH; Natarajan R; Ha H
Diabetologia; 2013 Jul; 56(7):1661-9. PubMed ID: 23604552
[TBL] [Abstract][Full Text] [Related]
35. Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.
Cardona SM; Mendiola AS; Yang YC; Adkins SL; Torres V; Cardona AE
ASN Neuro; 2015; 7(5):. PubMed ID: 26514658
[TBL] [Abstract][Full Text] [Related]
36. Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway.
Qin C; Fan WH; Liu Q; Shang K; Murugan M; Wu LJ; Wang W; Tian DS
Stroke; 2017 Dec; 48(12):3336-3346. PubMed ID: 29114096
[TBL] [Abstract][Full Text] [Related]
37. Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.
Kuboi Y; Nishimura M; Ikeda W; Nakatani T; Seki Y; Yamaura Y; Ogawa K; Hamaguchi A; Muramoto K; Mizuno K; Ogasawara H; Yamauchi T; Yasuda N; Onodera H; Imai T
Int Immunol; 2019 Apr; 31(5):287-302. PubMed ID: 30668715
[TBL] [Abstract][Full Text] [Related]
38. Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury.
Febinger HY; Thomasy HE; Pavlova MN; Ringgold KM; Barf PR; George AM; Grillo JN; Bachstetter AD; Garcia JA; Cardona AE; Opp MR; Gemma C
J Neuroinflammation; 2015 Sep; 12():154. PubMed ID: 26329692
[TBL] [Abstract][Full Text] [Related]
39. Ginsenoside Rg1 prevents vascular intimal hyperplasia involved by SDF-1α/CXCR4, SCF/c-kit and FKN/CX3CR1 axes in a rat balloon injury.
Hu A; Shuai Z; Liu J; Huang B; Luo Y; Deng J; Liu J; Yu L; Li L; Xu S
J Ethnopharmacol; 2020 Oct; 260():113046. PubMed ID: 32504784
[TBL] [Abstract][Full Text] [Related]
40. Post-stroke DHA Treatment Protects Against Acute Ischemic Brain Injury by Skewing Macrophage Polarity Toward the M2 Phenotype.
Cai W; Liu S; Hu M; Sun X; Qiu W; Zheng S; Hu X; Lu Z
Transl Stroke Res; 2018 Dec; 9(6):669-680. PubMed ID: 30203370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
